pyridoxamine has been researched along with Heart Disease, Ischemic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyridoxamine treatment decreased glycation and restored the activation of JNK and Akt during ischemia." | 1.39 | Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia. ( Almeida, F; Crisóstomo, J; Gonçalves, L; Matafome, P; Rodrigues, T; Santos-Silva, D; Seiça, R; Sena, C, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, F | 1 |
| Santos-Silva, D | 1 |
| Rodrigues, T | 1 |
| Matafome, P | 1 |
| Crisóstomo, J | 1 |
| Sena, C | 1 |
| Gonçalves, L | 1 |
| Seiça, R | 1 |
| Boyden, PA | 1 |
| Davies, SS | 1 |
| Viswanathan, PC | 1 |
| Amarnath, V | 1 |
| Balser, JR | 1 |
| Roberts, LJ | 1 |
1 review available for pyridoxamine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; F2-Isoprostanes; Humans; Lipid Peroxidation; Molecular Structure; Myo | 2007 |
1 other study available for pyridoxamine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Glycation End Products, Advanced; JNK | 2013 |